Therabest Japan concluded advisory agreements with Prof. Megumu Saito and Associate Prof. Akitsu Hot...
Read MoreMission Statement
Therabest Japan is dedicated to combining innovative biotechnology to create therapies that can improve the lives of many people by combating complex diseases.
Message from CEO
Therabest Japan Inc. is a research based pharmaceutical company that develops iPSC-derived cell therapies. There are many patients in the world who suffer from intractable diseases. One of our goals is to provide innovative treatment opportunities to those patients through our iPSC-derived cell therapy platform. We will also improve their quality of life by restoring patients’ immune systems to help them return to their daily lives. We will further advance our iPSC-derived cell therapy platform technology and pioneer the development of leading therapeutics through in-depth research and continual iteration of our technology.